标题
Body Weight Considerations in the Management of Type 2 Diabetes
作者
关键词
Antihyperglycemia therapy, GLP-1 RA, Insulin, Lifestyle, Obesity, Type 2 diabetes, Weight-loss, Weight management
出版物
ADVANCES IN THERAPY
Volume 36, Issue 1, Pages 44-58
出版商
Springer Nature
发表日期
2018-11-21
DOI
10.1007/s12325-018-0824-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2018 EXECUTIVE SUMMARY
- (2018) Alan J. Garber et al. Endocrine Practice
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation
- (2017) Rhona Johnston et al. HEALTH TECHNOLOGY ASSESSMENT
- Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes
- (2017) Melanie Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus
- (2017) Jian Li et al. MEDICINE
- Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes
- (2017) Virginia Valentine et al. Diabetes Therapy
- Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes
- (2017) Virginia Valentine et al. Diabetes Therapy
- Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes
- (2016) Sven Kohler et al. CLINICAL THERAPEUTICS
- Network meta-analysis of treatments for type 2 diabetes mellitus following failure with metformin plus sulfonylurea
- (2016) G. Lozano-Ortega et al. CURRENT MEDICAL RESEARCH AND OPINION
- Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial
- (2016) Julio Rosenstock et al. DIABETES CARE
- Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial
- (2016) H. W. Rodbard et al. DIABETIC MEDICINE
- Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes
- (2016) Ildiko Lingvay et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of canagliflozin in patients with type 2 diabetes
- (2016) Wei Xiong et al. MEDICINE
- Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
- (2016) Nick Freemantle et al. BMJ Open
- SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis
- (2016) Deepson S Shyangdan et al. BMJ Open
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
- (2016) Sultan Linjawi et al. Diabetes Therapy
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
- (2016) Sultan Linjawi et al. Diabetes Therapy
- Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2016) Heidi Storgaard et al. PLoS One
- Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus
- (2015) Przemyslaw Rys et al. ACTA DIABETOLOGICA
- Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus
- (2015) Ian J Neeland et al. Diabetes & Vascular Disease Research
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revisiting weight reduction and management in the diabetic patient: Novel therapies provide new strategies
- (2015) Stanley Schwartz et al. POSTGRADUATE MEDICINE
- The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus
- (2015) Gareth R. Dutton et al. PROGRESS IN CARDIOVASCULAR DISEASES
- The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans
- (2015) Lingling Fang et al. Adipocyte
- Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis
- (2015) Elizabeth S. Mearns et al. PLoS One
- Type 2 diabetes as a disease of ectopic fat?
- (2014) Naveed Sattar et al. BMC Medicine
- Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)
- (2014) John B. Buse et al. DIABETES CARE
- Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus
- (2014) W.D. Strain et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of metformin on weight loss
- (2014) Steven K. Malin et al. Current Opinion in Endocrinology Diabetes and Obesity
- Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
- (2014) Stephen C L Gough et al. Lancet Diabetes & Endocrinology
- Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes
- (2014) André J Scheen et al. Lancet Diabetes & Endocrinology
- GLP-1 receptor agonists: a review of head-to-head clinical studies
- (2014) Jennifer M. Trujillo et al. Therapeutic Advances in Endocrinology and Metabolism
- Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes
- (2014) Bernard Peene et al. Therapeutic Advances in Endocrinology and Metabolism
- Breaking Down Patient and Physician Barriers to Optimize Glycemic Control in Type 2 Diabetes
- (2013) Stuart A. Ross AMERICAN JOURNAL OF MEDICINE
- Effect of Antihyperglycemic Agents Added to Metformin and a Sulfonylurea on Glycemic Control and Weight Gain in Type 2 Diabetes: A Network Meta-analysis
- (2013) Jorge L. Gross ANNALS OF INTERNAL MEDICINE
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis
- (2013) J. A. Hirst et al. DIABETOLOGIA
- Achievement of Goals in U.S. Diabetes Care, 1999–2010
- (2013) Mohammed K. Ali et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study
- (2013) Obesity
- Strategies for preventing type 2 diabetes: an update for clinicians
- (2013) Kaivan Khavandi et al. Therapeutic Advances in Chronic Disease
- Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practice
- (2012) Giuseppe Derosa et al. Archives of Medical Science
- Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study
- (2012) M. Peyrot et al. DIABETIC MEDICINE
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- Long-Term Risk of Incident Type 2 Diabetes and Measures of Overall and Regional Obesity: The EPIC-InterAct Case-Cohort Study
- (2012) PLOS MEDICINE
- Long-term Prevention of Mortality in Morbid Obesity Through Bariatric Surgery. A Systematic Review and Meta-analysis of Trials Performed With Gastric Banding and Gastric Bypass
- (2011) Antonio E. Pontiroli et al. ANNALS OF SURGERY
- Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?
- (2011) R. H. Eckel et al. DIABETES CARE
- Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of
- (2011) D. Giugliano et al. DIABETES CARE
- Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
- (2011) R. R. Wing et al. DIABETES CARE
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Efficacy and Harms of the Hypoglycemic Agent Pramlintide in Diabetes Mellitus
- (2010) N. J. Lee et al. ANNALS OF FAMILY MEDICINE
- The Effect of Oral Antidiabetic Agents on A1C Levels: A systematic review and meta-analysis
- (2010) D. Sherifali et al. DIABETES CARE
- Third-Party Reimbursement for Diabetes Care, Self-Management Education, and Supplies
- (2010) DIABETES CARE
- The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis
- (2010) D. Singh-Franco et al. DIABETES OBESITY & METABOLISM
- Relationship of Insulin Dose, A1c Lowering, and Weight in Type 2 Diabetes: Comparing Insulin Glargine and Insulin Detemir
- (2010) George Dailey et al. Diabetes Technology & Therapeutics
- Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
- (2010) Olivia J. Phung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
- (2009) Henry Buchwald et al. AMERICAN JOURNAL OF MEDICINE
- Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses
- (2009) D. S. Lasserson et al. DIABETOLOGIA
- Metformin therapy and clinical uses
- (2008) John HB Scarpello et al. Diabetes & Vascular Disease Research
- Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity
- (2008) S. R. Smith et al. DIABETES CARE
- Nutritionist Visits, Diabetes Classes, and Hospitalization Rates and Charges: The Urban Diabetes Study
- (2008) J. M. Robbins et al. DIABETES CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now